New Jersey Lab Must Repay $3.4 Million to Medicaid for Billing Violations
State audit finds the lab billed for drug tests without required physician signatures in nearly a quarter of reviewed instances.
State audit finds the lab billed for drug tests without required physician signatures in nearly a quarter of reviewed instances.
State regulators say the companies collected specimens without authorized provider orders, violating Hawaii law.
Teams complete whole human genome sequencing and analysis in under four hours, demonstrating potential for same-day NICU workflows.
The quality management system certification confirms commitment to delivering consistent products and services to the scientific community.
The pathologist served as joint plaintiff in successful lawsuit challenging FDA regulation of LDTs as medical devices.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
The deal positions Abbott to enter the US cancer screening and precision oncology diagnostics market with products including Cologuard and Oncotype DX tests.
Analysis of international surveillance data shows rising resistance to last-line antibiotics, with significant regional variations in treatment outcomes.